TD Securities (USA)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$8K Hold
59
0.07% 120
2015
Q4
$8K Sell
59
-90
-60% -$12.4K 0.07% 123
2015
Q3
$21K Sell
149
-106,987
-100% -$16.1M 0.19% 114
2015
Q2
$17.6M Buy
107,136
+11,296
+12% +$1.8M 0.24% 107
2015
Q1
$14.8M Sell
95,840
-6,666
-7% -$949K 0.22% 108
2014
Q4
$12.9M Buy
102,506
+6,577
+7% +$813K 0.18% 130
2014
Q3
$11.5M Sell
95,929
-1,839
-2% -$211K 0.19% 130
2014
Q2
$10.5M Buy
97,768
+5,076
+5% +$523K 0.17% 149
2014
Q1
$9.23M Sell
92,692
-11,535
-11% -$1.04M 0.16% 155
2013
Q4
$9.63M Buy
104,227
+1,867
+2% +$166K 0.16% 148
2013
Q3
$8.56M Sell
102,360
-55
-0.1% -$4.71K 0.16% 141
2013
Q2
$8.38M Buy
+102,415
New +$7.66M 0.17% 136

Other funds holding ELV

TD Securities (USA)'s ELV Position: Q1 2016 in Review

TD Securities (USA) held its Elevance Health (ELV) position steady in Q1 2016 at 59 shares worth $8K. The position accounts for 0.07% of the portfolio, ranked #120.

TD Securities (USA) first reported a position in ELV in Q2 2013 and has held it in 12 quarters since. The position peaked at $17.6M in Q2 2015. 771 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • TD Securities (USA) held 59 shares of Elevance Health worth $8K as of Q1 2016.
  • TD Securities (USA) left its Elevance Health share count unchanged in Q1 2016.
  • Elevance Health made up 0.07% of TD Securities (USA)'s portfolio in Q1 2016, its #120 holding.
  • TD Securities (USA) first reported a position in Elevance Health in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Elevance Health position peaked at $17.6M in Q2 2015.
  • 771 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.